Skip to main content

Table 2 Medical profiles and heights of the CAH participants

From: Health-related quality of life of female patients with congenital adrenal hyperplasia in Malaysia

Variables

CAH participants

Age group I

10–12 years

(n = 12)

Age group II

13–17 years

(n = 29)

Age group III

≥ 18 years

(n = 18)

Total

N = 59

f

%

f

%

f

%

f

%

CAH variants

 SW-CAH

7

58.3

18

62.1

15

83.3

40

67.8

 SV-CAH

5

41.7

11

37.9

2

11.1

18

30.5

 NC-CAH

0

0

1

5.6

1

1.7

Daily corticosteroid replacement

 Prednisolone

4

33.3

17

58.6

13

72.2

34

57.6

 Hydrocortisone

8

66.7

12

41.4

5

27.8

25

42.2

On mineralocorticoids

10

83.3

23

79.3

17

94.4

50

84.7

Hypertensive

0

0

3

10.3

3

16.7

6

10.2

Participants’ perceived compliance to medications

 Excellent

3

25.0

11

37.9

6

33.3

30

33.9

 Intermediate

8

66.7

13

44.8

8

44.4

29

49.2

 Poor

1

8.3

5

17.2

4

22.2

10

16.9

Other co-morbidities

1

8.3

9

31.0

7

38.9

17

28.8

Had precocious puberty

6

50.0

12

41.4

3

16.7

21

35.6

Learning disability

2

16.7

6

20.7

2

11.1

10

16.9

Affected sibling (s)

5

41.7

15

51.7

8

44.4

28

47.5

Height (cm), Mean (SD)

142.7 (9.0)

151.0 (6.8)

149.0 (5.6)

  

Obese or overweight

5

41.6

10

34.4

6

33.4

21

35.6